In this episode, Dr. Sherer discusses results from key studies reported at the 2020 International Congress on Drug Therapy in HIV Infection ( HIV Glasgow 2020 Virtual) , including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV, including COVID-19. Presenter: Renslow Sherer, MD Director, International HIV Training Center Profe...
Oct 22, 2020•52 min•Ep. 20
In this episode, Part 10 of an ongoing series, Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and HIV. After the update, Dr. Wong answers clinician questions on various aspects of COVID-19. Presenter: Wong Chen Seong, MBBS, MRCP(UK), FAMS Head , NCID Clinical HIV Programme Deputy Director , National HIV Programme National Centre for Infectious Diseases Consultant Department of Infectious Diseases Tan Tock Seng Hospital Programme Director NHG Infectious Diseases Reside...
Oct 16, 2020•36 min•Ep. 18
In this episode, Dr. Rath discusses results from key studies reported at the European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including studies on COVID-19 screening and diagnostics, vaccines, prevention strategies, social disparities, and therapeutics. Presenter: Barbara Rath, MD, PhD, HDR Co-founder & Chair The Vienna Vaccine Safety Initiative Research Director Université de Bourgogne Franche-Comté, France Honorary Professor Exe...
Oct 16, 2020•58 min•Ep. 19
In this episode, Part 9 of an ongoing series, Lynora Saxinger, MD, FRCPC, CTropMed, provides a brief update on key concepts in COVID-19 immunity and the latest information on treatment strategies. After the update, Dr. Saxinger answers clinician questions on various aspects of COVID-19. Presenter: Lynora Saxinger, MD, FRCPC, CTropMed Cochair , Scientific Advisory Group Alberta COVID-19 Emergency Coordination Centre Associate Professor Department of Medicine Division of Infectious Diseases Univer...
Oct 09, 2020•42 min•Ep. 17
In this episode, Part 8 of an ongoing series, Paul E. Sax, MD, provides a brief update on current treatment options for COVID-19. After the update, Dr. Sax answers clinician questions on various aspects of COVID-19. Presenter: Paul E. Sax, MD Clinical Director HIV Program and Division of Infectious Diseases Brigham and Women's Hospital Professor of Medicine Harvard Medical School Boston, Massachusetts Content based on an online CME program supported by an independent educational grant from Gilea...
Oct 06, 2020•39 min•Ep. 16
In this episode, W. David Hardy, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV. Presenter: W. David Hardy, MD Scientific and Medical Consultant Adjunct Professor of Medicine Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, Maryland Content based on an online CME program supported by an independent educational grant from ViiV Healthcare. Link to full program: https://bit.ly/34...
Oct 02, 2020•25 min•Ep. 15
In this episode, Part 7 of an ongoing 12-part COVID-19 series, Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS, provides a brief update on COVID-19 risk and prevention strategies among healthcare workers. After the update, Professor Leo answers clinician questions on various aspects of COVID-19. Presenter: Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Professor Lee Kong Chian School of Medicine Saw Swee Hock School of Public Health Nanyang Technological University National University of Singapore Senior Con...
Sep 25, 2020•34 min•Ep. 14
In this episode, Part 6 of an ongoing 12-part COVID-19 series, Jens D. Lundgren, MD, DMSc, provides a brief update on vaccine development and treatment strategies. After the update, Dr. Lundgren answers clinician questions on various aspects of COVID-19. Note that this podcast was recorded on August 4, 2020. Some information may have changed since that time. Presenter: Jens D. Lundgren, MD, DMSc Professor Rigshospitalet, University of Copenhagen Copenhagen, Denmark Director Centre of Excellence ...
Sep 23, 2020•38 min•Ep. 13
In this episode, Part 1 of an 4-part series, Dr. Joseph J. Eron, Jr., Professor Chloe Orkin, and Dr. Paul E. Sax, discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities. Presenters: Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology University of North Carolina School of Medicine Director , AIDS Clinical Trials Unit University of Nor...
Sep 17, 2020•39 min•Ep. 12
In this episode, Dr. Stefan Zeuzem discusses results from key viral hepatitis studies reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver, including important findings from the following reports: Update on global progress toward HCV elimination goals SToP-C: HCV treatment-as-prevention in Australian prisons SHARED cohort: correlates of treatment failure with GLE/PIB or SOF/VEL/VOX Trio Health: retreating HCV with GLE/PIB or ...
Sep 14, 2020•44 min•Ep. 11
In this episode, Part 5 of an ongoing 12-part COVID-19 series, David Heymann, BA, MD, DTM&H, provides a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission,. After the update, Professor Heymann answers critical clinician questions on COVID-19 transmission and mitigation. Presenter: David Heymann, BA, MD, DTM&H Professor, Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine; and Distinguished Fellow, Centre...
Sep 02, 2020•33 min•Ep. 10
In this episode, Dr. Sherer discusses results from key studies reported at the International AIDS Society’s 2020 Virtual COVID-19 Conference, including studies evaluating characteristics and predictors of COVID-19 mortality, factors associated with remdesivir clinical outcomes, the effect of hydroxychloroquine coadministration on remdesivir safety and efficacy, the effect of race/ethnicity on clinical outcomes with remdesivir, and sofosbuvir/daclatasvir plus lopinavir/ritonavir for the treatment...
Aug 19, 2020•44 min•Ep. 9
In this episode, Dr. Orkin discusses results from key studies reported at AIDS 2020: Virtual, with new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention. The overview includes: The ADVANCE trial comparing initial ART with DTG plus FTC/TAF, DTG plus FTC/TDF, or EFV/FTC/TDF A pooled analysis of randomized trials evaluating...
Aug 14, 2020•40 min•Ep. 8
In this episode, Part 4 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends and a concise summary of updates to the US National Institutes of Health and the Infectious Diseases Society of America recommendations for managing COVID-19. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management. Presenter: Vikramjit Mukherjee, MD Director, Medical Intensive Care Unit Bel...
Jul 23, 2020•33 min•Ep. 7
In this episode, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, discuss current evidence supporting the need for integrated addiction and infectious disease care and review the wide array of benefits that can be realized when these services are provided in tandem, ideally at the same clinic and by the same healthcare provider. Presenters: Christian B. Ramers, MD, MPH Associate Clinical Professor Division of Infectious Diseases Department of Medicine UC San Diego School of Medicine La Jol...
Jul 09, 2020•20 min•Ep. 6
In this episode, Part 3 of an ongoing 12-part COVID-19 series, Sharon Lewin, AO, FRACP, PhD, FAAHMS, provides a brief update on the latest incidence trends and a concise guide to the management of mild and moderate disease. After the update, Dr. Lewin answers critical clinician questions on COVID-19 transmission, diagnosis, and management. Presenter: Sharon Lewin, AO, FRACP, PhD, FAAHMS Director The Peter Doherty Institute for Infection and Immunity Professor of Infectious Diseases University of...
Jun 29, 2020•47 min•Ep. 5
In this episode, Part 2 of an ongoing 12-part COVID-19 series, Jens D. Lundgren, MD, DMSc, provides a brief update on the latest incidence trends, a concise guide to viral diagnostic testing, and new data on investigational treatment options. After the update, Dr. Lundgren answers critical clinician questions on COVID-19 transmission, diagnosis, and management. Presenter: Jens D. Lundgren, MD, DMSc Professor Director , Centre of Excellence for Health, Immunity and Infection (CHIP) Rigshospital U...
Jun 12, 2020•44 min•Ep. 4
In this episode, Dr. Gandhi discusses topline results from several studies investigating weight gain and metabolic outcomes with different antiretroviral therapy (ART) regimens among patients with HIV, including lipid level changes, cardiovascular disease risk, diabetes risk, and metabolic syndrome risk. The overview will include analyses from: The ADVANCE trial comparing initial ART with DTG plus FTC/TAF, DTG plus FTC/TDF, or EFV/FTC/TDF, including an examination of the influence of CYP2B6 poly...
Jun 05, 2020•17 min•Ep. 1
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management. Presenter: Vikramjit Mukherjee, MD Director, Medical Intensive Care Unit Bellevu...
Jun 05, 2020•40 min•Ep. 2
In this episode, Dr. Kuritzkes and Dr. Ramers provide a case-based discussion addressing several age-related comorbidities among people with HIV, including bone loss, renal impairment, cardiovascular disease, mental health disorders, and neurocognitive disorders. Their discussion includes analysis of key data from the following HIV studies: DRIVE-AHEAD: Neuropsychiatric Events With First-line DOR/3TC/TDF vs EFV/FTC/TDF TANGO: Renal and Bone Changes With Switch to DTG/3TC SWORD-1/2: Renal and Bon...
Jun 05, 2020•30 min•Ep. 3
